Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9158028rdf:typepubmed:Citationlld:pubmed
pubmed-article:9158028lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9158028lifeskim:mentionsumls-concept:C0040300lld:lifeskim
pubmed-article:9158028lifeskim:mentionsumls-concept:C0024264lld:lifeskim
pubmed-article:9158028lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:9158028lifeskim:mentionsumls-concept:C0028959lld:lifeskim
pubmed-article:9158028lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:9158028lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:9158028lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:9158028lifeskim:mentionsumls-concept:C2709199lld:lifeskim
pubmed-article:9158028pubmed:issue9lld:pubmed
pubmed-article:9158028pubmed:dateCreated1997-6-6lld:pubmed
pubmed-article:9158028pubmed:abstractTextIn discordant xenogeneic species combinations, vascularized transplants are hyperacutely rejected, due to binding of xenoreactive natural antibodies (XNA) to selected tissues of the graft, followed by activation of the complement and coagulation cascades. A major epitope recognized by human XNA is the terminal disaccharide Gal alpha(1,3)Gal. Poorly defined, early cell-mediated events also contribute to recognition and rejection of discordant xenografts, and we have suggested a role of natural killer (NK) lymphocytes in this process.lld:pubmed
pubmed-article:9158028pubmed:languageenglld:pubmed
pubmed-article:9158028pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9158028pubmed:citationSubsetIMlld:pubmed
pubmed-article:9158028pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9158028pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9158028pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9158028pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9158028pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9158028pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9158028pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9158028pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9158028pubmed:statusMEDLINElld:pubmed
pubmed-article:9158028pubmed:monthMaylld:pubmed
pubmed-article:9158028pubmed:issn0041-1337lld:pubmed
pubmed-article:9158028pubmed:authorpubmed-author:SandrinM SMSlld:pubmed
pubmed-article:9158028pubmed:authorpubmed-author:BendelJ PJPlld:pubmed
pubmed-article:9158028pubmed:authorpubmed-author:PardyBBlld:pubmed
pubmed-article:9158028pubmed:authorpubmed-author:InverardiLLlld:pubmed
pubmed-article:9158028pubmed:authorpubmed-author:StolzerA LALlld:pubmed
pubmed-article:9158028pubmed:authorpubmed-author:ClissiBBlld:pubmed
pubmed-article:9158028pubmed:issnTypePrintlld:pubmed
pubmed-article:9158028pubmed:day15lld:pubmed
pubmed-article:9158028pubmed:volume63lld:pubmed
pubmed-article:9158028pubmed:ownerNLMlld:pubmed
pubmed-article:9158028pubmed:authorsCompleteYlld:pubmed
pubmed-article:9158028pubmed:pagination1318-30lld:pubmed
pubmed-article:9158028pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:meshHeadingpubmed-meshheading:9158028-...lld:pubmed
pubmed-article:9158028pubmed:year1997lld:pubmed
pubmed-article:9158028pubmed:articleTitleHuman natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues.lld:pubmed
pubmed-article:9158028pubmed:affiliationHuman Immunology Unit, Scientific Institute San Raffaele-DIBIT, Milan, Italy.lld:pubmed
pubmed-article:9158028pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9158028pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9158028lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9158028lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9158028lld:pubmed